Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Schizophrenia

Free Subscription 20.04.2026 1 Am J Psychiatry 2 Br J Psychiatry 1 J Clin Psychiatry 4 Mol Psychiatry 1 Nat Genet 2 Neuropsychopharmacology 2 PLoS One 1 Psychiatry Res 15 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Psychiatry

1. KU SH, Stringfield SJ, Torregrossa MM, Sweet RA, et al
   Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.
   Am J Psychiatry. 2026 Apr 17:appiajp20250886. doi: 10.1176/appi.ajp.20250886.
   PubMed         Abstract available
   
   

   
   Br J Psychiatry

2. SMITH A, Griffin NP, Grana J, Buadze A, et al
   'Where you swim, she drowns': schizophrenia and Finnegans Wake (1939) - Psychiatry in literature.
   Br J Psychiatry. 2026;228:495-496.
   PubMed        
   
   
3. DE LA HOZ JF, Arias A, Service SK, Castano M, et al
   Characterisation of serious mental illness trajectories through transdiagnostic clinical features.
   Br J Psychiatry. 2026;228:446-453.
   PubMed         Abstract available
   
   

   
   J Clin Psychiatry

4. UMBRICHT D, Abt M, Derks M, Hernandez MC, et al
   A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia.
   J Clin Psychiatry. 2026;87:25m16022.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

5. CUI L, Kurganov E, Hawes D, Hornauer P, et al
   Loss of schizophrenia risk gene XPO7 disrupts neuronal excitability and network regularity via altered Na(+) channel dynamics in human neurons.
   Mol Psychiatry. 2026 Apr 15. doi: 10.1038/s41380-026-03587.
   PubMed         Abstract available
   
   
6. CHENG M, Yin Y, Engchuan W, Heung T, et al
   Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion.
   Mol Psychiatry. 2026 Apr 15. doi: 10.1038/s41380-026-03574.
   PubMed         Abstract available
   
   
7. MCKENNA F, Vinke LN, Williams M, Gaw M, et al
   Postpartum psychosis is associated with elevated neuromelanin-MRI signal in the midbrain.
   Mol Psychiatry. 2026 Apr 15. doi: 10.1038/s41380-026-03476.
   PubMed         Abstract available
   
   
8. FENNER E, Holmans P, O'Donovan MC, Owen MJ, et al
   Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank.
   Mol Psychiatry. 2026 Apr 10. doi: 10.1038/s41380-026-03601.
   PubMed         Abstract available
   
   

   
   Nat Genet

9. WU Y, Zheng Z, Thibaut L, Lin T, et al
   Genome-wide fine-mapping improves identification of causal variants.
   Nat Genet. 2026;58:940-951.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

10. HORNG JE, McCrea LT, Batorsky RE, Bowen JJ, et al
    Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators.
    Neuropsychopharmacology. 2026 Apr 16. doi: 10.1038/s41386-026-02406.
    PubMed         Abstract available
    
    
11. YANG BZ, He L, Liu TQ, Ma S, et al
    Causal links among gut microbiota, immune-inflammatory and compensatory immune-regulatory systems, and schizophrenia.
    Neuropsychopharmacology. 2026 Apr 15. doi: 10.1038/s41386-026-02407.
    PubMed         Abstract available
    
    

    
    PLoS One

12. BAMPOS C, Megalooikonomou V
    Exploration of schizophrenia-associated gene modules using graph theory, co-expression networks, and dimensionality reduction.
    PLoS One. 2026;21:e0346663.
    PubMed         Abstract available
    
    
13. BARBALAT G, Plasse J, Chereau-Boudet I, Gouache B, et al
    Are routinely collected clinical and sociodemographic characteristics associated with social functioning and activities of daily living in schizophrenia? A machine learning approach descriptive of a schizophrenia cohort.
    PLoS One. 2026;21:e0347326.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

14. DUDAKLI BB, Uzel HK, Ocak MS, Esen Oksuzoglu M, et al
    Changes in serum Nogo-A and BDNF levels following treatment in drug-naive first-episode schizophrenia: A naturalistic prospective study.
    Psychiatry Res. 2026;361:117149.
    PubMed         Abstract available
    
    

    
    Schizophr Res

15. MILLER CR, Taylor SF, Breier A, Vohs JL, et al
    Factor analysis of two COMPASS psychopathology symptom scales for first-episode psychosis.
    Schizophr Res. 2026;294:1-6.
    PubMed         Abstract available
    
    
16. GAGO E, Montalvo I, Cabezas A, Ortega L, et al
    Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosis.
    Schizophr Res. 2026;293:147-155.
    PubMed         Abstract available
    
    
17. NAGENDRA A, Mesholam-Gately RI, Shafrin J, Keshavan MS, et al
    Corrigendum to "Reframing schizophrenia as a neurodevelopmental syndrome: The scientific and social imperative" [Schizophr. Res. Volume 292, June 2026, pages 96-102].
    Schizophr Res. 2026 Apr 15:S0920-9964(26)00117.
    PubMed        
    
    
18. COHEN I, Bukowski E
    Predictors of antidepressant prescribing in schizophrenia: A retrospective analysis.
    Schizophr Res. 2026;293:144-146.
    PubMed        
    
    
19. GARCIA-SAN NICOLAS C, Diaz-Pons A, Paras C, Ortiz-Garcia de la Foz V, et al
    Exposome and cognition in psychosis: an exploratory study in sex-specific patterns in patients and their unaffected siblings.
    Schizophr Res. 2026;293:134-143.
    PubMed         Abstract available
    
    
20. PASCOE B, Cocks K, Clarke N, Langevin N, et al
    Structural and construct validity assessment of the schizophrenia cognition rating scale (SCoRS) using data from three international phase 3 randomized controlled trials (CONNEX programme).
    Schizophr Res. 2026;293:124-133.
    PubMed         Abstract available
    
    
21. WU CJ, Lin JJ, Huang CC, Tseng HH, et al
    Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder.
    Schizophr Res. 2026;293:113-123.
    PubMed         Abstract available
    
    
22. WERST MJA, Tiraboschi GA, Paquin V
    Digital cultures and the exposome of psychosis.
    Schizophr Res. 2026;293:109-112.
    PubMed        
    
    
23. KAMP D, Riesbeck M, Lowe A, Weide K, et al
    Predictors of gains in social functioning after cognitive remediation in schizophrenia: Results from the multicenter ISST (Integrated Social Cognition and Social Skills Therapy) trial.
    Schizophr Res. 2026;293:99-108.
    PubMed         Abstract available
    
    
24. HAMZAI HV, D'Arcey J, Jagtap S, Leibovitz T, et al
    The role of cognitive schemas in personal recovery, symptom severity, and functioning in schizophrenia-spectrum disorders.
    Schizophr Res. 2026;293:91-98.
    PubMed         Abstract available
    
    
25. SHIVAKUMAR G, Szymaniak K, Bell E, Malhi GS, et al
    Schizoaffective disorder - A conglomerated disorder that needs an amalgamation of ideas.
    Schizophr Res. 2026;292:60-68.
    PubMed         Abstract available
    
    
26. DALLOUL N, Kandala S, Moran E, Barch DM, et al
    Negative symptoms and resting state functional connectivity: Leveraging ecological momentary assessment and individual-specific techniques.
    Schizophr Res. 2026;292:28-40.
    PubMed         Abstract available
    
    
27. RICHARDS SE, Davis A, Blake C, Errington H, et al
    Challenges and priorities in researching and managing altered perceptual experiences: Shared academic and lived experience perspectives.
    Schizophr Res. 2026;292:12-20.
    PubMed         Abstract available
    
    
28. PILLNY M, Edwards CJ, Riehle M
    Beyond the emotion paradox: Avenues to understanding anhedonia in schizophrenia.
    Schizophr Res. 2026;294:17-26.
    PubMed         Abstract available
    
    
29. PRETTYMAN GE, Kales E, Didier P, Savage C, et al
    Impaired intrinsic motivation in psychosis risk relates to ventral striatum activation to self-generated reinforcement signals.
    Schizophr Res. 2026;294:7-16.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum